Experimental pill that promises new hope for deadly pancreatic cancer accelerated A randomized clinical trial showed that patients receiving daraxonrasib achieved a median survival of 13.2 months
These were the 10 most outstanding medical advances of 2025 The international scientific community demonstrated an extraordinary capacity for innovation this year
Pancreatic cancer, one of the most aggressive Unlike other types of cancer where medical advances have improved survival rates, pancreatic cancer has remained a challenge
